Show results for
Refine by
Autoimmune Suppliers Serving Ecuador
108 companies found
based inCrumlin, UNITED KINGDOM
BBI Solutions offer a portfolio of products and services that are delivered to the diagnostic and life science industries globally. BBI Solutions has been serving the global diagnostics industry for over 50 years and is the world’s largest ...
based inStockholm, SWEDEN
Diamyd Medical is a clinical-stage diabetes company active in the field of pharmaceutical development. We develop two novel disease-modifying drugs: the antigenspecific immunotherapy Diamyd and the oral regenerative and immunomodulatory therapeutic ...
based inWindsor, NOVA SCOTIA (CANADA)
BioMedica Diagnostics is a specialized company offering diagnostic solutions with a strong focus on Thrombosis and Haemostasis. The company collaborates globally with technology development firms and healthcare stakeholders to engineer and ...
based inHuningue, FRANCE
FIRALIS is a biotechnology company located in the very heart of BioValley, on the true triple border of FR-DE-CH, only a few minutes walking distance to Basel, the pharmaceutical capital of Europe. Firalis creates novel values via biomarker ...
As part of the European IMI BT-Cure consortium followed by the H2020 RABIOPRED program launched in 2016, FIRALIS launches its proprietary assay for the identification of markers related to inflammatory-autoimmune ...
based inWuhan, CHINA
Mulei (Wuhan) New Material Technology Co. Ltd is a scientific and technological company integrating product research and development manufacturing and trading of chemical intermediates, specialized in organic intermediates, pharmaceutica ...
based inZug, SWITZERLAND
SHL Medical is a world-leading solutions provider in the design, development, and manufacturing of advanced delivery devices such as autoinjectors, pen injectors, and innovative specialty delivery systems for large-volume and high-viscosity ...
based inBedminster, NEW JERSEY (USA)
Jubilant Therapeutics Inc. is a clinical stage precision therapeutics company advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. With an advanced discovery engine which ...
Strong scientific and clinical rationale for PAD4 inhibitors in autoimmune ...
based inGermantown, MARYLAND (USA)
Cell and gene therapies (CGTs) use modified cells or cellular matter to treat, prevent or cure serious health issues like cancer, genetic disorders, immunodeficiencies, rare diseases, and more. CGTs have shown potential to replace damaged cells with ...
based inWroclaw, POLAND
Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based ...
based inBasel, SWITZERLAND
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people™s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare “ a ...
based inCambridge, MASSACHUSETTS (USA)
We are a group of individuals who know that there is a better way to develop drugs. Our business model and broad, science-based portfolio has attracted some of the brightest minds in drug development. Our team brings together more than 300 years of ...
based inIrvine, CALIFORNIA (USA)
We create the products and technologies that drive the advancement of aesthetic medicine. At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Eldelumab selectively binds to CXCL10 and blocks CXCL10-induced calcium flux and cell migration. Eldelumab can be used in studies of autoimmune and auto-inflammatory diseases such as rheumatoid arthritis, ulcerative colitis and ...
based inDallas, TEXAS (USA)
Lupagen is a privately held early stage biotech company developing first-in-class bedside enabled cell & gene therapies (CAR-T cell, gene editing and immunotherapy products) based on their patent-pending bedside point-of-care C and GT production and ...
based inIrvine, CALIFORNIA (USA)
MP Biomedicals is a worldwide corporation developing, manufacturing and distributing products for the life science, in vitro diagnostics (IVD), fine chemicals and dosimetry markets. Through our global operational network, we provide research and ...
based inCleveland, OHIO (USA)
Cellular Technology Limited (CTL) is a biotechnology company headquartered in Shaker Heights, a suburb of Cleveland, Ohio, with locations and distributors worldwide. We presently have around 180 full-time employees. Our company is family owned and ...
based inBrno, CZECH REPUBLIC
TestLine Clinical Diagnostics Ltd. (Hereinafter TestLine) is a Czech company engaged in development, manufacturing and distribution of both human and veterinary diagnostics. Our broad spectrum of in vitro diagnostics and knowledge in the field of ...
based inParis, FRANCE
Enterome is pioneering the discovery and development of novel pharmaceuticals based on its unrivalled understanding of the interaction between the gut microbiome and the immune system – the Microbiome-Immunoinflammation Axis. Enterome is using this ...
New generation of oral bioactives to treat inflammatory and autoimmune diseases. EndoMimicsTM are first-in-class orally available bioactives drugs based on proteins secreted by the gut bacteria that act like human hormones or ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Augurex develops biomarkers that transform patient clinical management for better disease outcomes by helping diagnose patients, whom when identified can be promptly treated. By biologically informing a clinical assessment, biomarkers optimize ...
14-3-3η is not normally present outside of cells. Therefore, in the disease state, the body views it as foreign and mounts an immune response in an attempt to clear it. This immune response generates14-3-3η specific auto-antibodies that are ...
based inDoylestown, PENNSYLVANIA (USA)
Neuropathix, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing a patented product platform of novel molecules from our proprietary socially responsible pain management therapeutics to treat patients with a ...
